XML 37 R27.htm IDEA: XBRL DOCUMENT v3.26.1
EQUITY COMPENSATION PLANS (Tables)
3 Months Ended
Mar. 31, 2026
Share-Based Payment Arrangement [Abstract]  
Schedule of RSAs transaction activity
        
   Restricted Common Stock Award Shares   Weighted Average Grant Date Fair Value ($) 
Unvested balance at December 31, 2025   17,617    3.10 
Granted        
Vested   (2,524)   2.11 
Forfeited        
Unvested balance at March 31, 2026   15,093    3.27 
Schedule of RSUs transaction activity
        
   Restricted Common Stock Unit Shares   Weighted Average Grant Date Fair Value ($) 
Outstanding at December 31, 2025   617,236    9.13 
Granted        
Vested and settled   (339,555)   9.15 
Forfeited        
Outstanding at March 31, 2026   277,681    9.12 
Unvested at March 31, 2026   277,681    9.12 
Schedule of stock option transaction activity
        
   Number of Stock Options   Grant Date Weighted Average Exercise Price ($) 
Outstanding at December 31, 2025   1,841,977    6.51 
Options granted        
Options exercised        
Options canceled and forfeited        
Outstanding at March 31, 2026   1,841,977    6.51 
Schedule of stock-based compensation expense
              
   Three Months Ended March 31, 
   2026   2025 
Research and development  $156,670   $128,926 
General and administrative   1,199,719    996,175 
Total  $1,356,389   $1,125,101